These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 27519951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tracing the progression of retinitis pigmentosa via photoreceptor interactions.
    Camacho ET, Wirkus S.
    J Theor Biol; 2013 Jan 21; 317():105-18. PubMed ID: 23063618
    [Abstract] [Full Text] [Related]

  • 4. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
    Komeima K, Rogers BS, Campochiaro PA.
    J Cell Physiol; 2007 Dec 21; 213(3):809-15. PubMed ID: 17520694
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
    Xue Y, Wang SK, Rana P, West ER, Hong CM, Feng H, Wu DM, Cepko CL.
    Elife; 2021 Apr 13; 10():. PubMed ID: 33847261
    [Abstract] [Full Text] [Related]

  • 8. Role of the sigma-1 receptor chaperone in rod and cone photoreceptor degenerations in a mouse model of retinitis pigmentosa.
    Yang H, Fu Y, Liu X, Shahi PK, Mavlyutov TA, Li J, Yao A, Guo SZ, Pattnaik BR, Guo LW.
    Mol Neurodegener; 2017 Sep 19; 12(1):68. PubMed ID: 28927431
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa.
    John SK, Smith JE, Aguirre GD, Milam AH.
    Mol Vis; 2000 Nov 03; 6():204-15. PubMed ID: 11063754
    [Abstract] [Full Text] [Related]

  • 12. Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.
    Zhang L, Justus S, Xu Y, Pluchenik T, Hsu CW, Yang J, Duong JK, Lin CS, Jia Y, Bassuk AG, Mahajan VB, Tsang SH.
    Hum Mol Genet; 2016 Oct 01; 25(19):4244-4255. PubMed ID: 27516389
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spatio-temporal characterization of S- and M/L-cone degeneration in the Rd1 mouse model of retinitis pigmentosa.
    Narayan DS, Ao J, Wood JPM, Casson RJ, Chidlow G.
    BMC Neurosci; 2019 Sep 03; 20(1):46. PubMed ID: 31481030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Testing for a gap junction-mediated bystander effect in retinitis pigmentosa: secondary cone death is not altered by deletion of connexin36 from cones.
    Kranz K, Paquet-Durand F, Weiler R, Janssen-Bienhold U, Dedek K.
    PLoS One; 2013 Sep 03; 8(2):e57163. PubMed ID: 23468924
    [Abstract] [Full Text] [Related]

  • 19. A review of the mechanisms of cone degeneration in retinitis pigmentosa.
    Narayan DS, Wood JP, Chidlow G, Casson RJ.
    Acta Ophthalmol; 2016 Dec 03; 94(8):748-754. PubMed ID: 27350263
    [Abstract] [Full Text] [Related]

  • 20. Metabolic Deregulation of the Blood-Outer Retinal Barrier in Retinitis Pigmentosa.
    Wang W, Kini A, Wang Y, Liu T, Chen Y, Vukmanic E, Emery D, Liu Y, Lu X, Jin L, Lee SJ, Scott P, Liu X, Dean K, Lu Q, Fortuny E, James R, Kaplan HJ, Du J, Dean DC.
    Cell Rep; 2019 Jul 30; 28(5):1323-1334.e4. PubMed ID: 31365873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.